Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neptune Wellness Solutions Inc NEPTF

Neptune Wellness Solutions Inc. is a consumer-packaged goods company that is primarily focused on health and wellness products. The Company focuses on developing a portfolio of consumer products that align with the market trends for natural, sustainable, plant-based, and purpose-driven lifestyle brands. Its products are available in more than 29,000 retail locations and include organic food and beverage brands, such as Sprout Organics, Nosh, and Nurturme, as well as nutraceuticals brands like Biodroga and Forest Remedies. Its main brand units are nutraceuticals and organic foods and beverages. The Company sells its nutraceutical products mainly in bulk soft gels or liquids to multiple distributors and customers, who commercialize these products under their private label. The Company, through its Sprout subsidiary, sells its organic foods and beverages products to mass retailers, grocery stores and other retail outlets, as well as online through e-commerce sites and its own Website.


PINL:NEPTF - Post by User

Post by gwrbion Nov 09, 2010 6:48pm
354 Views
Post# 17683583

Investor indifference

Investor indifference
Since the webcast last week the stock has gone sideways to slightly down.

I thought the webcast was pretty well done and was informative.  I took from it that the company has a definite plan, and Dr. Tina is very passionate about achieving it.  Management fully intends to take this company the next few steps on their own, and will have the mandate and the capital to do it.

This board has whined for years about the lack of communication, well now the level of communication is almost over the top.

I see the investor indifference, in spite of the continued positive communication, as due to two possibilities.  One being there will be no quick sell out here, and management will plod along trying to achieve the value-add themselves - and the cynics aren't happy with that.

Secondly, there remains a lot of uncertainty about Acasti, and the exercise of the warrants, and related spin out.  Since the company is trading at a very low value ($2), the market isn't assigning a dime of value to the Acasti opportunity.  And now, the company will raise almost $10M from the warrants, for an initiative the market isn't assigning any value to.  This creates implied dilution.  A bunch more shares issued with no value increase (other than cash).  Thus the trade sideways to down.

I find it amazing that all the references to GSK's acquisition of Lovaze for $1.65B in 2007 (and how CaPre could be far superior) haven't done anything for the NTB SP.  $1.65B for one product line represents the equivalent of $40/share for NTB, and yet we remain in the $2 range.

I am definitely warming up to the direction management is taking, and more than willing to await the slower, but still certain, value-appreciation.
Bullboard Posts